Cameron Turtle
Chief Executive Officer at Spyre Therapeutics Inc.
Sits on 3 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 3 boards, counting each seat separately. Longest: Spyre Therapeutics Inc., 2 years.
Chief executive roles
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 1, 2026 | Spyre Therapeutics Inc. | Open-market sale | −600 | $89.14 | $53,484 |
| Oct 1, 2026 | Spyre Therapeutics Inc. | Open-market sale | −2,683 | $90.10 | $241,738 |
| Oct 1, 2026 | Spyre Therapeutics Inc. | Open-market sale | −2,638 | $91.49 | $241,351 |
| Oct 1, 2026 | Spyre Therapeutics Inc. | Open-market sale | −3,989 | $92.31 | $368,225 |
| Oct 1, 2026 | Spyre Therapeutics Inc. | Open-market sale | −4,990 | $93.37 | $465,916 |
| Oct 1, 2026 | Spyre Therapeutics Inc. | Open-market sale | −100 | $93.91 | $9,391 |
| Sep 1, 2026 | Spyre Therapeutics Inc. | Open-market sale | −2,500 | $86.36 | $215,900 |
| Sep 1, 2026 | Spyre Therapeutics Inc. | Open-market sale | −8,400 | $87.15 | $732,060 |
| Sep 1, 2026 | Spyre Therapeutics Inc. | Open-market sale | −3,700 | $88.06 | $325,822 |
| Sep 1, 2026 | Spyre Therapeutics Inc. | Open-market sale | −400 | $89.07 | $35,628 |
| Aug 3, 2026 | Spyre Therapeutics Inc. | Open-market sale | −800 | $93.97 | $75,176 |
| Aug 3, 2026 | Spyre Therapeutics Inc. | Open-market sale | −7,157 | $95.10 | $680,631 |
| Aug 3, 2026 | Spyre Therapeutics Inc. | Open-market sale | −5,635 | $95.93 | $540,566 |
| Aug 3, 2026 | Spyre Therapeutics Inc. | Open-market sale | −1,392 | $96.82 | $134,773 |
| Aug 3, 2026 | Spyre Therapeutics Inc. | Open-market sale | −16 | $97.46 | $1,559 |
Questions about Cameron Turtle
What boards is Cameron Turtle on?
Cameron Turtle sits on the boards of Damora Therapeutics Inc., Oruka Therapeutics Inc. and Spyre Therapeutics Inc.
What company is Cameron Turtle the CEO of?
Cameron Turtle is Chief Executive Officer of Spyre Therapeutics Inc.
How long has Cameron Turtle served on boards?
Our records show at least 6 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.